APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chemo-induced bone marrow failure? drug trial aims to boost blood cells
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in 43 adults whose bone marrow has stopped making enough blood cells after chemotherapy or radiation. The goal is to see if the drug can improve blood counts and reduce the need for transfusions. Participants must have tried other tr…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Cord blood cells aim to break transfusion dependence in aplastic anemia
Disease control Not yet recruitingThis study tests a new treatment called CK0801 for adults with aplastic anemia who still need blood transfusions after standard therapy. CK0801 uses immune cells from donated cord blood to help the body make its own blood cells again. The trial will check if the treatment is safe…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a platelet booster help kids with bone marrow failure?
Disease control Not yet recruitingThis phase II trial tests whether adding romiplostim, a drug that stimulates platelet production, to standard immunosuppressive therapy can improve blood cell counts in children and young adults with severe aplastic anemia. The study will enroll 15 participants aged 2 to 21 who a…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Anjali Sharathkumar • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for tough anemia: daratumumab trial launches
Disease control Not yet recruitingThis study tests daratumumab, a drug that targets certain immune cells, in 37 people with aplastic anemia that hasn't improved with standard treatments. The first part checks safety and the right dose, and the second part looks at whether it can improve blood cell counts. The goa…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC